The deficiency of ADAMTS13, which was also observed in blood samples from COVID-19 patients, results in disseminated microvascular thrombosis, characteristic of thrombotic thrombocytopenic purpura (TTP) (67, 70). This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.